Silence Therapeutics - Litigation Update (Portugal and US)

Silence Therapeutics plc, AIM: SLN a leader in the discovery, delivery, and development of novel RNA therapeutics for the treatment of serious diseases with unmet medical need, announces that, through Silence Therapeutics Gmbh, it has yesterday brought patent infringement proceedings in Portugal against Alnylam's Patisiran product, and that on March 29 th...